Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05898087
PHASE4

Subpectoral Bupivacaine for Pain Management in Adolescent Reduction Mammaplasty

Sponsor: Connecticut Children's Medical Center

View on ClinicalTrials.gov

Summary

The main question this randomized control trial aims to answer is: • Is the use of intraoperative subpectoral bupivacaine associated with decreased post-operative pain in adolescent patients who undergo bilateral reduction mammaplasty Participants will be randomized into the study group that intraoperatively receives 30cc of subpectoral bupivacaine injections or into the control group that intraoperatively receives 30cc of injectable saline subpectorally. All participants will keep a pain log and pain medication log at home for the first week following surgery. Researchers will compare to see if patients who receive subpectoral bupivacaine have lower pain scores in the PACU, and lower use of narcotics post-operatively when compared to the control group who receive injectable saline.

Key Details

Gender

All

Age Range

13 Years - 25 Years

Study Type

INTERVENTIONAL

Enrollment

128

Start Date

2022-04-01

Completion Date

2026-04-01

Last Updated

2025-05-29

Healthy Volunteers

Yes

Interventions

DRUG

Marcaine 0.25 % Injectable Solution

Patients in this arm will receive an injection of 20cc of injectable 0.25% bupivacaine solution. It will be injected in a fan-like pattern beneath the pectoralis fascia

DRUG

Saline

Patients in this arm will receive an injection of 20cc of injectable saline. It will be injected in a fan-like pattern beneath the pectoralis fascia

Locations (2)

Connecticut Children's

Farmington, Connecticut, United States

Connecticut Children's

Hartford, Connecticut, United States